Abiopharma

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Cirrus Logic to Present at Upcoming Conference

PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Western Metallica Resources Corp. Announces Exclusivity and Binding Option Agreement for Nueva Celti Copper Project

INTU Investors Have Opportunity to Lead Intuit Inc. Securities Fraud Lawsuit

New SEC Form for ResMed Inc.

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

Saputo Announces Election of Directors